LL-37 (5mg)

Login to view prices.

Existing research has found the following:

  • Supports Antimicrobial Peptide Research – Studied for its broad-spectrum activity against bacterial, viral, and fungal pathogens in experimental models.

  • Explores Immune Modulation Pathways – Investigated for its role in enhancing innate immune response and coordinating host defense mechanisms.

  • Evaluates Wound Healing & Tissue Repair – Examined for promoting epithelial regeneration and accelerating skin and soft tissue recovery.

Description


Antimicrobial Mechanisms and Host-Defense Models

  • LL-37, a cationic amphipathic peptide derived from the human cathelicidin gene (CAMP), has been widely studied in pre-clinical and cellular models for its broad-spectrum antimicrobial properties against bacteria, fungi, and enveloped viruses.

Innate-Immunity and Immune-Modulation Research

  • In in-vitro and animal studies, LL-37 has been shown to influence immune-cell recruitment, cytokine balance, and Toll-like receptor signaling, supporting investigations into innate-defense and immunomodulatory pathways.

Wound-Healing and Tissue-Repair Studies

  • Pre-clinical literature reports that LL-37 promotes keratinocyte migration, angiogenesis, and epithelial regeneration, providing a framework for studying cellular-repair and wound-closure mechanisms.

Inflammatory and Autoimmune-Response Models

  • LL-37 has demonstrated context-dependent effects on inflammatory cascades in non-clinical systems, making it a key compound for exploring cytokine regulation and immune-homeostasis research relevant to chronic-inflammation models.

Gastrointestinal-Barrier and Microbiome Research

  • Experimental data show that LL-37 may help preserve intestinal-barrier integrity and modulate gut microbial balance, supporting studies into epithelial-defense and mucosal-immunity mechanisms.

Respiratory-Epithelium and Infection Models

  • LL-37 has been used in pre-clinical respiratory studies to examine antimicrobial protection and immune modulation within pulmonary tissue, aiding investigation of airway inflammation and infection response.

Autoimmunity and Immune-Tolerance Studies

  • Laboratory research suggests LL-37 may influence self-antigen recognition and immune-complex dynamics, enabling further exploration of autoimmune and inflammatory-signaling pathways.

STORAGE DETAILS

Lyophilized LL-37 peptide is stable at room temperature for 90 days; however, it should NOT be stored below freezing for any extended period. After reconstitution, refrigerate at ≤36°F.

Product Specifications

  • Appearance: Solid, white powder in 3mL glass ampule

  • Chemical Formula: C177H293N51O43

  • PubChem CID: (Specify if available)

  • CAS Number: 219685-50-4

  • Molecular Weight: 4493.23 g/mol

  • Synonyms: LL-37, CAP-18, FALL-39, 219685-50-4

  • Storage: Store at ≤6°C, sealed, away from heat, light, and moisture.

  • Concentration: ≥98%

    Research Use Only (RUO). Not for human or animal use. Not for diagnostic, therapeutic, or clinical applications. No claims are made regarding antimicrobial, wound-healing, or immune-support benefits in humans. End-user assumes responsibility for determining suitability for specific research protocols.

You may also like